Latest AI and machine learning research in genetics for healthcare professionals.
Personalized cancer care depends on the seamless integration of genetic profiles, medical histories, and continuous patient monitoring to optimize therapeutic outcomes. Current clinical strategies struggle to combine these disparate, highly heterogeneous data streams, frequently resulting in incomplete diagnostic evaluations and suboptimal treatment selections. Factors such as poor cross-platform ...
The heterogeneity and complex tumor microenvironment of lung adenocarcinoma lead to poor prognosis. Autophagy, as a key cellular process, interacts with tumor immune infiltration and jointly affects the progression of lung adenocarcinoma, but its core regulatory genes and mechanisms are still unclear.This study integrated three lung adenocarcinoma transcriptome datasets from the GEO database and p...
Alcohol Use Disorder (AUD) is a prevalent neuropsychiatric condition affecting about 28 million adults in the USA, with few objective biomarkers to as...
BACKGROUND, AIMS: Gastric cancer (GC) pathogenesis involves complex molecular interactions that remain incompletely understood at a biological systems...
Small interfering RNA (siRNA) therapeutics has huge potential for treating many diseases, including those incurable or undruggable by small molecules ...
Local brain age (LBA) is a spatially resolved biomarker of brain aging that captures regional deviations from chronological age, yet its genetic archi...
Epilepsy is the 4th most prevalent neurological condition with 50 million cases worldwide. Patients with epilepsy bare a disproportionate burden of co...
Glioma stem cells (GSCs) drive tumor heterogeneity, therapy resistance, and immunosuppression. This study identified molecular subtypes of glioma base...
The Qinghai-Tibet Plateau (QTP) is a representative alpine arid region characterized by arsenic (As) enrichment and selenium (Se) deficiency in soils....
Vestibular schwannoma (VS) is a benign tumor originating from the vestibular nerve, and its complex tumor microenvironment presents significant challe...
BACKGROUND: There is broad agreement that the onset of bipolar disorders (BD) can be predicted by using combined estimates of familial, genetic and cl...
Virtual screening (VS) stands as a cornerstone of early-stage drug discovery, yet long-standing hurdles-including prohibitive computational cost and l...
Point mutations within the SARS-CoV-2 nucleocapsid protein (NP) have the potential to impact not only detection but the viral life cycle, and therefor...
Genetic mutations frequently disrupt protein structure, stability, and solubility, acting as primary drivers for a wide spectrum of diseases. Despite ...
Schizophrenia (SCZ) is a highly heritable psychiatric disorder, yet its genetic links with chronic pulmonary diseases remain poorly defined. Such link...
BACKGROUND AND AIMS: Prognostic biomarkers that link disease progression and/or responses to therapeutic interventions in patients with primary biliar...
Deep mutational scanning (DMS) has proven effective for mapping protein-protein interactions (PPIs), but it cannot provide complete coverage of the mu...
BACKGROUND: The histological differentiation grade of gastric cancer critically influences treatment and prognosis. While CT radiomics shows promise f...
BACKGROUND: Cervical cancer (CC) is a main malignancy affecting women globally, with a high mortality rate. Chemoradiotherapy resistance is a signific...
The Protein Data Bank (PDB), established in 1971, is the primary global, open-access archive for experimentally determined 3D macromolecular structure...